Unknown

Dataset Information

0

CD47 blockade enhances therapeutic activity of TCR mimic antibodies to ultra-low density cancer epitopes.

ABSTRACT:

SUBMITTER: Mathias MD 

PROVIDER: S-EPMC5628131 | biostudies-literature | 2017 Oct

REPOSITORIES: biostudies-literature

Json Xml
altmetric image

Publications

CD47 blockade enhances therapeutic activity of TCR mimic antibodies to ultra-low density cancer epitopes.

Mathias M D MD   Sockolosky J T JT   Chang A Y AY   Tan K S KS   Liu C C   Garcia K C KC   Scheinberg D A DA  

Leukemia 20170712 10

Similar Datasets

Unknown TCR-mimic bispecific antibodies to target the HIV-1 reservoir.
| S-EPMC9169739 | biostudies-literature
Unknown CD47 blockade enhances phagocytosis of cardiac cell debris by neutrophils.
| S-EPMC10507185 | biostudies-literature
Unknown TCR-mimic bispecific antibodies targeting LMP2A show potent activity against EBV malignancies.
| S-EPMC5916246 | biostudies-literature
Unknown A Novel Blockade CD47 Antibody With Therapeutic Potential for Cancer.
| S-EPMC7813985 | biostudies-literature
Unknown Tumor-Directed Blockade of CD47 with Bispecific Antibodies Induces Adaptive Antitumor Immunity.
| S-EPMC6698848 | biostudies-literature
Unknown Acute CD47 Blockade During Ischemic Myocardial Reperfusion Enhances Phagocytosis-Associated Cardiac Repair.
| S-EPMC5595371 | biostudies-literature
Unknown Trispecific targeting of T cells engineered with TCR mimic antibodies to limit antigen escape.
| S-EPMC12815101 | biostudies-literature
Unknown Disulfiram/Copper Induces Immunogenic Cell Death and Enhances CD47 Blockade in Hepatocellular Carcinoma.
| S-EPMC9564202 | biostudies-literature
Unknown CXCR2 inhibition in G-MDSCs enhances CD47 blockade for melanoma tumor cell clearance.
| S-EPMC10835053 | biostudies-literature
Unknown CD47-targeting antibodies as a novel therapeutic strategy in hematologic malignancies.
| S-EPMC8455363 | biostudies-literature